HCLTech Share Price Gains Over 3%; Acquires 10.46% Stake in Sarvam AI for ₹1,427 Crore

HCL Technologies Limited has announced a strategic investment of ₹1,427 crore in Axonwise Private Limited, known as Sarvam AI, acquiring a 10.46% stake.  

This move aims to bolster AI capabilities in sectors such as banking, insurance, and government technology. 

HCLTech's Investment in Sarvam AI 

On June 15, 2026, HCLTech disclosed its investment in Sarvam AI, acquiring 41,421 equity shares for a 10.46% stake.  

The investment will support Sarvam's research and development in AI models for agentic, coding, and cybersecurity applications. 

Purpose Behind the Investment 

The investment by HCLTech is intended to fund Sarvam AI's ongoing research and development efforts.  

It aims to expand the deployment of AI solutions across key industry verticals, leveraging HCLTech's global client relationships and expertise. 

Timeline of the Investment 

The investment was announced on June 15, 2026, with completion expected within 2 weeks of signing. The transaction involves a 100% cash consideration. 

Location and Presence of Sarvam AI 

Sarvam AI, headquartered in Bengaluru, India, focuses on developing AI models across text, speech, vision, and documents.  

The company partners with leading Indian enterprises, including SBI Life and Tata Capital. 

HCL Technologies Share Price Performance 

As of June 16, 2026, at 10:28 AM, HCL Technologies share price on NSE was trading at ₹1,158.20 up by 3.48% from the previous closing price. 

Read More: Happiest Minds Technologies Introduces Rel(AI) Build for AI-Driven Enterprise Software Development! 

Conclusion 

HCLTech's ₹1,427 crore investment in Sarvam AI secures a 10.46% stake, supporting AI research and development. This strategic move aims to enhance AI capabilities across sectors like banking and government technology. 

For daily market updates and regular stock market news in Hindi, stay tuned to Angel One's share market news in Hindi. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.